{"title":"Paradigm-changing osimertinib approval in front-line for advanced NSCLC","authors":"J. de Lartigue","doi":"10.12788/jcso.0435","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of community and supportive oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/jcso.0435","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}